Targeting of the MAPK and AKT pathways in conjunctival melanoma shows potential synergy

Author(s):
Cao, J.F.; Heijkants, R.C.; Jochemsen, A.G. (0000-0002-0570-7967); Dogrusoz, M.; Lange, M.J. de; Velden, P.A. van der; Burg, S.H. van der (0000-0002-6556-0354); Jager, M.J.; Verdijk, R.M.
Published
2017
Publication type
Article / Letter to editor
conjunctival melanomaMAPKAKTnevuskinase inhibitor
Date issued
2017-08-29
Language
English
Is part of
Oncotarget (2017), Vol. 8, no. 35, p. 58021-58036
hdl
1887/115154
doi
10.18632/oncotarget.10770